BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16584165)

  • 21. Devising new drugs for the treatment of hypertension--"novel drugs targeting hypertension: renin inhibitors and beyond".
    Booz GW
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):1-2. PubMed ID: 17666908
    [No Abstract]   [Full Text] [Related]  

  • 22. Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride.
    Mishra D; Garg M; Dubey V; Jain S; Jain NK
    J Pharm Sci; 2007 Jan; 96(1):145-55. PubMed ID: 16960826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemistry, manufacturing and controls in passive transdermal drug delivery systems.
    Goswami T; Audett J
    Ther Deliv; 2015; 6(9):1071-9. PubMed ID: 26389777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapy.
    Abraham PA; Halstenson CE; Matzke GR; Keane WF
    J Clin Hypertens; 1987 Dec; 3(4):439-51. PubMed ID: 3330986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of component of microemulsion for transdermal delivery of nicardipine hydrochloride.
    Wu PC; Lin YH; Chang JS; Huang YB; Tsai YH
    Drug Dev Ind Pharm; 2010 Dec; 36(12):1398-403. PubMed ID: 20545507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the SPRINT Blood Pressure Treatment Target of 120/80 mm Hg Relevant for Children?
    Falkner B; Gidding SS
    Hypertension; 2016 May; 67(5):826-8. PubMed ID: 27021011
    [No Abstract]   [Full Text] [Related]  

  • 27. Quality of life on antihypertensive therapy: a double-blind trial comparing quality of life on pinacidil and nifedipine in combination with a thiazide diuretic. European Pinacidil Study Group.
    Fletcher AE; Battersby C; Adnitt P; Underwood N; Jurgensen HJ; Bulpitt CJ
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):108-14. PubMed ID: 1383618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of a losartan potassium released from a transdermal therapeutic system for the treatment of hypertension.
    Shams MS; Alam MI; Ali A; Sultana Y; Aqil M; Shakeel F
    Pharmazie; 2010 Sep; 65(9):679-82. PubMed ID: 21038845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of pinacidil and prazosin on blood pressure, weight, plasma volume, the renin-angiotensin-aldosterone system, and the renal kallikrein-kinin system in patients with essential hypertension.
    Solomon RJ; Weinberg MS
    J Clin Hypertens; 1987 Dec; 3(4):589-95. PubMed ID: 3330989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Transdermal treatment of hypertension].
    Rosenfeld J
    Harefuah; 1988 Feb; 114(4):210-1. PubMed ID: 3356394
    [No Abstract]   [Full Text] [Related]  

  • 31. Transdermal delivery of carvedilol in rats: probing the percutaneous permeation enhancement mechanism of soybean extract-chitosan mixture.
    Sapra B; Jain S; Tiwary AK
    Drug Dev Ind Pharm; 2009 Oct; 35(10):1230-41. PubMed ID: 19555244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Transdermal therapeutic systems].
    Makó S; Stampf G
    Acta Pharm Hung; 2001 Oct; 71(3):293-9. PubMed ID: 11961896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of experimental hypertension in rats by prolonged administration of a combination of antihypertensive agents].
    Ghaye-Roquet J; Jousse S; Ganter P
    Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):14-22. PubMed ID: 5111321
    [No Abstract]   [Full Text] [Related]  

  • 34. Novel oral formulation approach for poorly water-soluble drug using lipocalin-type prostaglandin D synthase.
    Mizoguchi M; Nakatsuji M; Inoue H; Yamaguchi K; Sakamoto A; Wada K; Inui T
    Eur J Pharm Sci; 2015 Jul; 74():77-85. PubMed ID: 25906910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic characteristics of formulated alendronate transdermal delivery systems in rats and humans.
    Choi A; Gang H; Whang J; Gwak H
    Drug Deliv; 2010 May; 17(4):249-54. PubMed ID: 20214414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and evaluation of occlusive systems employing polyvinyl alcohol for transdermal delivery of sumatriptan succinate.
    Balaguer-Fernández C; Padula C; Femenía-Font A; Merino V; Santi P; López-Castellano A
    Drug Deliv; 2010 Feb; 17(2):83-91. PubMed ID: 20067437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic delivery of antihypertensive drugs via skin.
    Güngör S; Ozsoy Y
    Ther Deliv; 2012 Sep; 3(9):1101-16. PubMed ID: 23035594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ask the experts: transdermal drug delivery.
    Ther Deliv; 2013 Oct; 4(10):1235-8. PubMed ID: 24116908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pinacidil-induced vascular relaxation: comparison to other vasodilators and to classical mechanisms of vasodilation.
    Cohen ML; Kurz KD
    J Cardiovasc Pharmacol; 1988; 12 Suppl 2():S5-9. PubMed ID: 2466179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel drugs targeting hypertension: renin inhibitors and beyond.
    Leibovitz E; Schiffrin EL
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):3-8. PubMed ID: 17666909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.